Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease

Summary

The purpose of this study is to evaluate the effect of treatment with 0.017% P-321 on Dry Eye Symptoms.

Timeline

Start

2016-07

Primary completion

2017-06

Completion

2017-06

Outcome

Missed primary endpoint

registry analysis (superiority test); Placebo Ophthalmic Solution vs 0.017% P-321 Ophthalmic Solution; p = 0.749 NCT02831387 ↗

Drugs

Indications